GLOBAL INVESTIGATION OF THERAPEUTIC DECISIONS IN HEPATOCELLULAR CARCINOMA (HCC) AND OF ITS TREATMENT WITH SORAFENIB (GIDEON): IMPACT OF LIVER DYSFUNCTION ON SORAFENIB TREATMENT IN EUROPE

被引：1

作者：

Mathurin, P. ^{[1
]}

Castells, L. ^{[2
]}

Bodoky, G. ^{[3
]}

Stal, P. ^{[4
,5
]}

Bronowicki, J. -P. ^{[6
]}

Gerolami, R. ^{[7
]}

Daniele, B. ^{[8
]}

Vazquez, J. T. ^{[9
]}

Serejo, F. ^{[10
]}

Croitoru, A. ^{[11
]}

Hubert, A. ^{[12
]}

Gorbunova, V. ^{[13
]}

Ratziu, V. ^{[14
,15
]}

Papandreou, C. ^{[16
]}

机构：

[1] Univ Lille Nord France, Serv Malad Appareil Digestif, Hop Claude Huriez, Lille, France

[2] Hosp Valle De Hebron, Barcelona, Spain

[3] St Laszlo Teaching Hosp, Dept Oncol, Budapest, Hungary

[4] Karolinska Univ Hosp, Dept Gastroenterol & Hepatol, Stockholm, Sweden

[5] Karolinska Inst, Dept Med Huddinge, Stockholm, Sweden

[6] Univ Nancy 1, INSERM Unite 954, Ctr Hosp Univ Nancy, Vandoeuvre Les Nancy, France

[7] Hop Conception, Serv Hepatogastroenterol, Ctr Hosp Univ, Marseille, France

[8] G Rummo Hosp, Dept Med Oncol, Benevento, Italy

[9] Complejo Hosp Pontevedra, Dept Gastroenterol, Hosp Montecelo, Pontevedra, Spain

[10] Hosp Santa Maria, Ctr Gastroenterol, Liver Unit, Fac Med, Lisbon, Portugal

[11] FUNDENI Clin Inst, Dept Med Oncol, Bucharest, Romania

[12] Hadassah Hebrew Univ Hosp, Gastrointestinal Canc Ctr, Sharett Inst Oncol, Jerusalem, Israel

[13] Inst Russian Acad Med Sci, Russian Sci Res Oncol Ctr, Moscow, Russia

[14] Univ Paris 06, Paris, France

[15] Hosp Pitie Salpetriere, Paris, France

[16] Univ Hosp Larissa, Dept Med Oncol, Larisa, Greece

来源：

JOURNAL OF HEPATOLOGY | 2012年 / 56卷

关键词：

D O I：

10.1016/S0168-8278(12)61033-2

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

1021

引用

页码：S399 / S400

页数：2

共 50 条

[1] REAL-WORLD MANAGEMENT OF HCC WITH SORAFENIB AND TACE IN EUROPE FROM GIDEON (GLOBAL INVESTIGATION OF THERAPEUTIC DECISIONS IN HCC AND OF ITS TREATMENT WITH SORAFENIB)
Stal, P.
Hubert, A.
Daniele, B.
Bronowicki, J. -P.
Mathurin, P.
Gerolami, R.
Bodoky, G.
Vazquez, J. T.
Serejo, F.
Croitoru, A.
Castells, L.
Gorbunova, V.
Ratziu, V.
Papandreou, C.
JOURNAL OF HEPATOLOGY, 2012, 56 : S404 - S405
[2] GIDEON (Global Investigation of therapeutic DEcisions in hepatocellular carcinoma and Of its treatment with sorafeNib): second interim analysis
Lencioni, R.
Kudo, M.
Ye, S. -L.
Bronowicki, J. -P.
Chen, X. -P.
Dagher, L.
Furuse, J.
Geschwind, J. F.
Ladron de Guevara, L.
Papandreou, C.
Takayama, T.
Yoon, S. K.
Nakajima, K.
Lehr, R.
Heldner, S.
Sanyal, A. J.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2014, 68 (05) : 609 - 617
[3] First interim results of the global investigation of therapeutic decisions in hepatocellular carcinoma (HCC) and of its treatment with sorafenib (GIDEON) study: Use of sorafenib (Sor) by oncologists and nononcologists in the management of HCC
Venook, A. P.
Lencioni, R.
Marrero, J. A.
Kudo, M.
Nakajima, K.
Ye, S.
JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (04)
[4] FIRST INTERIM RESULTS OF THE GLOBAL INVESTIGATION OF THERAPEUTIC DECISIONS IN HEPATOCELLULAR CARCINOMA AND OF ITS TREATMENT WITH SORAFENIB (GIDEON) STUDY
Lencioni, R.
Lim, H. Y.
Stal, P.
Marrero, J. A.
Kudo, M.
Venook, A. P.
Nakajima, K.
Ye, S. L.
ANNALS OF ONCOLOGY, 2010, 21 : 258 - 259
[5] Worldwide trends in locoregional therapy for hepatocellular carcinoma (HCC): Second interim analysis of the Global Investigation of Therapeutic Decisions in HCC and of Its Treatment with Sorafenib (GIDEON) study
Geschwind, Jeff H.
Lencioni, Riccardo
Marrero, Jorge A.
Venook, Alan Paul
Ye, Sheng-Long
Nakajima, Keiko
Cihon, Frank
Kudo, Masatoshi
JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (04)
[6] Final analysis of GIDEON (Global Investigation of Therapeutic Decisions in Hepatocellular Carcinoma [HCC] and of Its Treatment with Sorafenib [Sor]) in >3000 Sortreated patients (pts): Clinical findings in pts with liver dysfunction
Marrero, Jorge A.
Lencioni, Riccardo
Ye, Sheng-Long
Kudo, Masatoshi
Bronowicki, Jean-Pierre
Chen, Xiao-Ping
Dagher, Lucy
Furuse, Junji
Geschwind, Jean-Francois
Ladron de Guevara, Laura
Papandreou, Christos
Sanyal, Arun J.
Takayama, Tadatoshi
Yoon, Seung Kew
Nakajima, Keiko
Venook, Alan Paul
JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
[7] GIDEON (GLOBAL INVESTIGATION OF THERAPEUTIC DECISIONS IN HCC AND OF ITS TREATMENT WITH SORAFENIB): EUROPEAN INTERIM SAFETY AND DOSING SUBANALYSIS
Papandreou, Christos
Ratziu, Vlad
Gorbunova, Vera
Mathurin, Philippe
Castells, Lluis
Bodoky, Gyoergy
Stal, Per
Bronowicki, Jean-Pierre
Gerolami, Rene
Daniele, Bruno
Vazquez, Juan Turnes
Serejo, Fatima
Croitoru, Adina
Hubert, Ayala
ANNALS OF ONCOLOGY, 2012, 23 : 52 - 52
[8] Second interim analysis of the Global Investigation of Therapeutic Decisions in Unresectable HCC and of Its Treatment with Sorafenib (GIDEON): Sorafenib dosing and safety in US patients
El-Khoueiry, Anthony B.
Piperdi, Bilal
Goldenberg, Alec
Cohn, Allen Lee
Geschwind, Jeff H.
Marrero, Jorge A.
Sanyal, Arun
Venook, Alan Paul
JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (04)
[9] Design and rationale for the non-interventional Global Investigation of therapeutic DEcisions in hepatocellular carcinoma and Of its treatment with sorafeNib (GIDEON) study
Lencioni, R.
Marrero, J.
Venook, A.
Ye, S. -L.
Kudo, M.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2010, 64 (08) : 1034 - 1041
[10] SORAFENIB TREATMENT AND SAFETY PROFILE IN CHILD PUGH B PATIENTS CHARACTERIZED IN FIRST INTERIM RESULTS OF GIDEON (GLOBAL INVESTIGATION OF THERAPEUTIC DECISIONS IN HEPATOCELLULAR CARCINOMA AND OF ITS TREATMENT WITH SORAFENIB)
Marrero, Jorge A.
Lim, Ho Yeong
Stal, Per
Lencioni, Riccardo
Kudo, Masatoshi
Venook, Alan
Nakajima, Keiko
Ye, Sheng-Long
HEPATOLOGY, 2010, 52 (04) : 1140A - 1140A

← 1 2 3 4 5 →